𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis

✍ Scribed by Michael F. Picco; Murli Krishna; John R. Cangemi; Donna Shelton


Book ID
110087079
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
217 KB
Volume
12
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Direct comparison of two different mesal
✍ Hiroaki Ito; Mitsuo Iida; Takayuki Matsumoto; Yasuo Suzuki; Hidetaka Sasaki; Toy πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

Background: Mesalamine is the first-line drug for the treatment of ulcerative colitis (UC). We directly compared the efficacy and safety of two mesalamine formulations for the induction of remission in patients with UC. ## Methods: In a multicenter, double-blind, randomized study, 229 patients wit

Direct comparison of two different mesal
✍ Hiroaki Ito; Mitsuo Iida; Takayuki Matsumoto; Yasuo Suzuki; Yoshiyuki Aida; Toyo πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 240 KB πŸ‘ 2 views

Background: Mesalamine has been used as the first-line medication for the treatment of ulcerative colitis (UC). We directly compared the efficacy and safety of two different mesalamine formulations in the maintenance of remission in patients with UC. ## Methods: In a multicenter, double-blind, ran